199 related articles for article (PubMed ID: 21719060)
1. Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome.
Okawada M; Holst JJ; Teitelbaum DH
Surgery; 2011 Aug; 150(2):217-23. PubMed ID: 21719060
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
Sueyoshi R; Woods Ignatoski KM; Okawada M; Hartmann B; Holst J; Teitelbaum DH
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(4):G410-9. PubMed ID: 24970775
[TBL] [Abstract][Full Text] [Related]
3. Intestinal adaptation in proximal and distal segments: Two epithelial responses diverge after intestinal separation.
Schall KA; Holoyda KA; Isani M; Schlieve C; Salisbury T; Khuu T; Debelius JW; Moats RA; Pollack HA; Lien CL; Fowler K; Hou X; Knight R; Grikscheit TC
Surgery; 2017 Apr; 161(4):1016-1027. PubMed ID: 28011012
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 2 increases efficacy of distraction enterogenesis.
Sueyoshi R; Ralls MW; Teitelbaum DH
J Surg Res; 2013 Sep; 184(1):365-73. PubMed ID: 23639355
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
[TBL] [Abstract][Full Text] [Related]
9. Differential action of TGR5 agonists on GLP-2 secretion and promotion of intestinal adaptation in a piglet short bowel model.
Lin S; Stoll B; Robinson J; Pastor JJ; Marini JC; Ipharraguerre IR; Hartmann B; Holst JJ; Cruz S; Lau P; Olutoye O; Fang Z; Burrin DG
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G641-G652. PubMed ID: 30920308
[TBL] [Abstract][Full Text] [Related]
10. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
12. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study.
Naimi RM; Hvistendahl MK; Thomassen LM; Johnsen H; Christiansen CB; Holst JJ; Hartmann B; Jeppesen PB
BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 33975891
[TBL] [Abstract][Full Text] [Related]
13. Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum.
Slim GM; Lansing M; Wizzard P; Nation PN; Wheeler SE; Brubaker PL; Jeppesen PB; Wales PW; Turner JM
JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):891-898. PubMed ID: 30614011
[TBL] [Abstract][Full Text] [Related]
14. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
[TBL] [Abstract][Full Text] [Related]
15. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.
Taqi E; Wallace LE; de Heuvel E; Chelikani PK; Zheng H; Berthoud HR; Holst JJ; Sigalet DL
J Pediatr Surg; 2010 May; 45(5):987-95. PubMed ID: 20438940
[TBL] [Abstract][Full Text] [Related]
16. Chronically administered retinoic acid has trophic effects in the rat small intestine and promotes adaptation in a resection model of short bowel syndrome.
Wang L; Tang Y; Rubin DC; Levin MS
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1559-69. PubMed ID: 17307727
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet.
Baldassano S; Amato A; Cappello F; Rappa F; Mulè F
J Endocrinol; 2013 Apr; 217(1):11-20. PubMed ID: 23308022
[TBL] [Abstract][Full Text] [Related]
18. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
[TBL] [Abstract][Full Text] [Related]
19. Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection.
Hitch MC; Leinicke JA; Wakeman D; Guo J; Erwin CR; Rowland KJ; Merrick EC; Heuckeroth RO; Warner BW
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1143-50. PubMed ID: 22421622
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease.
Xiao Q; Boushey RP; Cino M; Drucker DJ; Brubaker PL
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R1057-63. PubMed ID: 10749795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
